Taxonomic Analysis of Asteroids with Artificial Neural Networks
Luo, Nanping, Wang, Xiaobin, Gu, Shenghong, Penttilä, Antti, Muinonen, Karri, Liu, Yisi
Published in The Astronomical journal (01.01.2024)
Published in The Astronomical journal (01.01.2024)
Get full text
Journal Article
Stellar Cycle and Evolution of Polar Spots in an M+WD Binary
Zhao, Xinlin, Wang, Song, Li, Xue, Xiang, Yue, Xu, Fukun, Gu, Shenghong, Du, Bing, Liu, Jifeng
Published in The Astrophysical journal (01.03.2024)
Published in The Astrophysical journal (01.03.2024)
Get full text
Journal Article
The study on transmission spectrum and TTV behaviour of the hot Jupiter WASP-12b
Bai, Lu, Gu, Shenghong, Wang, Xiaobin, Sun, Leilei, Kwok, Chi-Tai, Hui, Ho-Keung
Published in Monthly notices of the Royal Astronomical Society (31.03.2022)
Published in Monthly notices of the Royal Astronomical Society (31.03.2022)
Get full text
Journal Article
850-P: Greater HbA1c Reduction with iGlarLixi vs. Insulin Glargine and Lixisenatide Regardless of Levels at Screening: Subgroup Analysis of the LixiLan-O Asia Pacific Trial
HE, YIFAN, YANG, WENYING, XIAOLIN, DONG, YUAN, GUOYUE, LIU, MING, XIAO, JIANZHONG, GU, SHENGHONG, CHEN, LIJUAN, SOUHAMI, ELISABETH
Published in Diabetes (New York, N.Y.) (01.06.2022)
Published in Diabetes (New York, N.Y.) (01.06.2022)
Get full text
Journal Article
Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan‐L‐CN randomized controlled trial
Yuan, Xiaoyong, Guo, Xiaohui, Zhang, Junqing, Dong, Xiaolin, Lu, Yibing, Pang, Wuyan, Gu, Shenghong, Niemoeller, Elisabeth, Ping, Lin, Nian, Gaowei, Souhami, Elisabeth
Published in Diabetes, obesity & metabolism (01.11.2022)
Published in Diabetes, obesity & metabolism (01.11.2022)
Get full text
Journal Article
Efficacy and safety benefits of iGlarLixi versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with suboptimally controlled type 2 diabetes on oral agents: The LixiLan‐O‐AP randomized controlled trial
Yang, Wenying, Dong, Xiaolin, Li, Qingju, Cheng, Zhifeng, Yuan, Guoyue, Liu, Ming, Xiao, Jianzhong, Gu, Shenghong, Niemoeller, Elisabeth, Chen, Lijuan, Ping, Lin, Souhami, Elisabeth
Published in Diabetes, obesity & metabolism (01.08.2022)
Published in Diabetes, obesity & metabolism (01.08.2022)
Get full text
Journal Article
A method of photometric data extraction for asteroids from time-domain surveys
Xu, Xiaoyun, Wang, Xiaobing, Muinonen, Karri, Penttilä, Antti, Luo, Nanping, Gu, Shenghong, Sun, Leilei, Xu, Fukun, Liu, Yisi, Xiang, Yue, Cao, Dongtao, Wang, Jianhua
Published in Monthly notices of the Royal Astronomical Society (01.05.2023)
Published in Monthly notices of the Royal Astronomical Society (01.05.2023)
Get full text
Journal Article
WASP-35 and HAT-P-30/WASP-51: Reanalysis using TESS and Ground-based Transit Photometry
Bai, Lu, Gu, Shenghong, Wang, Xiaobin, Sun, Leilei, Kwok, Chi-Tai, Hui, Ho-Keung
Published in The Astronomical journal (01.05.2022)
Published in The Astronomical journal (01.05.2022)
Get full text
Journal Article
iGlarLixi provides a higher derived time‐in‐range versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with type 2 diabetes: A post hoc analysis
Guo, Xiaohui, Yang, Wenying, Zhang, Junqing, Dong, Xiaolin, Liu, Ming, Gu, Shenghong, Lauand, Felipe, Li, Lingyu, Huang, Qiong, Kang, Lei, Souhami, Elisabeth
Published in Diabetes, obesity & metabolism (01.07.2023)
Published in Diabetes, obesity & metabolism (01.07.2023)
Get full text
Journal Article
Active longitudes and starspot evolution of the young rapidly rotating star USNO-B1.0 1388−0463685 discovered in the Yunnan–Hong Kong survey
Luo, Xiang, Gu, Shenghong, Xiang, Yue, Wang, Xiaobin, Yeung, Bill, Ng, Eric, Bai, Jinming, Fan, Yufeng, Xu, Fukun, Cao, Dongtao, Sun, Leilei, Liu, Yisi, Wang, Jianhua, Bai, Lu, Xu, Xiaoyun
Published in Monthly notices of the Royal Astronomical Society (11.06.2022)
Published in Monthly notices of the Royal Astronomical Society (11.06.2022)
Get full text
Journal Article
iGlarLixi provides a higher derived time‐in‐range versus insulin glargine 100U/mL or lixisenatide in Asian Pacific people with type 2 diabetes: A post hoc analysis
Guo, Xiaohui, Yang, Wenying, Zhang, Junqing, Dong, Xiaolin, Liu, Ming, Gu, Shenghong, Lauand, Felipe, Li, Lingyu, Huang, Qiong, Kang, Lei, Souhami, Elisabeth
Published in Diabetes, obesity & metabolism (01.07.2023)
Published in Diabetes, obesity & metabolism (01.07.2023)
Get full text
Journal Article